Protocols · Metabolic
Vitamin B12 (cyanocobalamin / methylcobalamin) dosage protocol
Dosage and protocol information sourced exclusively from PeptideDosages.com.
Read this first
Dosage and protocol figures on this page are reproduced only from the matching PeptideDosages.com protocol. The 3 ml table is arithmetic based on those source amounts and the listed vial sizes. Educational research only — not instructions or medical advice.
Dosage protocol
PeptideDosages.com does not currently publish a matching protocol for Vitamin B12 (cyanocobalamin / methylcobalamin). No dosage, schedule, reconstitution figure, or syringe-unit calculation is shown on this page.
Check the source protocol indexOther metabolic compounds
Vitamin B12 (cyanocobalamin / methylcobalamin): research background
What the compound is
Vitamin B12, also known as cobalamin, is a water-soluble vitamin. It is acquired through animal-derived foods like eggs, milk, red meat, poultry, fish, and shellfish (PMID 36669740). It is a micronutrient crucial for hematopoiesis (the formation of blood cells) and neurological function (PMID 41156524).
How it is thought to work
Vitamin B12 acts as a cofactor for enzymes such as methionine synthase and methylmalonyl-CoA mutase, which are involved in DNA methylation and nucleotide synthesis. These processes are essential for DNA replication and transcription (PMID 37375638). Vitamin B12 also possesses antioxidant properties, which help protect DNA from damage by scavenging free radicals and reducing oxidative stress (PMID 37375638). Its deficiency can lead to indirect DNA damage (PMID 37375638). In neuropsychiatric contexts, mechanisms underlying its manifestations include alterations in one-carbon metabolism, genetic vulnerability, and changes in folate metabolism (PMID 35337631).
What laboratory and human studies report
Vitamin B12 deficiency in humans can manifest as neuropsychiatric symptoms, including depression, anxiety, psychosis, dementia, and delirium (PMID 35337631). Other mental changes observed in humans include apathy, agitation, impaired concentration, insomnia, persecutory delusions, auditory and visual hallucinations, and disorganized thought processes (PMID 35337631). Maintaining high serum B12 levels in elderly humans may protect against Alzheimer's disease (AD), and its deficiency in established AD is associated with higher cognitive decline and delirium risk (PMID 35337631). Deficiency can also lead to megaloblastic anemia and peripheral neuropathy in humans (PMID 35706595). In humans with cancer, vitamin B12 deficiency is linked to anemia and can worsen chemotherapy-induced peripheral neuropathy (PMID 41156524). High levels of vitamin B12 in humans have been associated with renal failure, liver diseases (like cirrhosis and acute hepatitis), alcohol use disorder, solid tumors (lung, liver, esophagus, pancreas, colorectum), and hematological malignancies (leukemia, bone marrow dysplasia) (PMID 36669740). In vitro, cobalamins can generate DNA-damaging radicals and are being researched for use as vectors for xenobiotics (PMID 37375638).
Open questions and limitations
The exact contribution of vitamin B12 deficiency to cancer-related anemia remains underexplored (PMID 41156524). While prevalence estimates for deficiency in cancer populations range widely (6-48%), there is a need for improved diagnostic accuracy in oncology settings (PMID 41156524). Research is ongoing regarding the emerging immunological role of B12 in cancer therapy (PMID 41156524).
Key terms explained
Hematopoiesis refers to the process of blood cell formation (PMID 41156524). Megaloblastic anemia is a type of anemia where bone marrow produces unusually large, structurally abnormal, immature red blood cells (PMID 35706595). Peripheral neuropathy involves damage to nerves outside of the brain and spinal cord (PMID 35706595). One-carbon metabolism is a network of biochemical reactions involving transfers of single-carbon units, essential for processes like DNA synthesis and methylation (PMID 35337631). Holotranscobalamin, methylmalonic acid (MMA), and homocysteine are laboratory markers used, alongside serum vitamin B12, to diagnose B12 status (PMID 35337631, PMID 41156524).
Studies cited in this section
- Neuropsychiatric manifestations in vitamin B12 deficiency. — Vitamins and hormones, 2022 (PMID 35337631)
- Vitamin B12 in Cancer Patients: Clinical Insights into Deficiency, Excess, Diagnosis, and Management. — Nutrients, 2025 (PMID 41156524)
- Vitamin B12: For more than just the treatment of megaloblastic anemia? — Revista clinica espanola, 2023 (PMID 36669740)
- Vitamin B12 and Plant-Predominant Diets. — American journal of lifestyle medicine, 2022 (PMID 35706595)
- Vitamin B12-Multifaceted In Vivo Functions and In Vitro Applications. — Nutrients, 2023 (PMID 37375638)
Summarised from the PubMed abstracts listed above. Educational reference only — not medical advice or instructions.
Nearby in the protocol A–Z
Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.